Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.31
Delayed Data
As of Sep 20
 +0.02 / +0.61%
Today’s Change
1.93
Today|||52-Week Range
3.77
+56.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues53.6M66.5M45.4M143.8M
 
 
 
 
 
Cost of Goods Sold--4.1M2.6M4.5M
 
 
 
 
Depreciation And Amortization6.0M6.0M6.0M6.1M
 
 
 
 
 
 
Operating ExpensesGross Income--56.4M36.9M133.2M
 
 
 
 
General Expenses12.3M15.0M16.9M19.2M
 
 
 
 
 
Research And Development1.9M1.9M1.8M4.3M
 
 
 
 
 
Total Operating Expenses18.4M25.1M25.5M29.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income35.3M41.4M19.9M114.0M
 
 
 
 
 
Extraordinary Credit--5.8M0.00--
 
 
Extraordinary Charge-2.6M-57.2M-1.4M-1.2M
 
 
 
 
 
Interest Expense On Debt4.5M4.7M5.0M5.0M
 
 
 
 
 
Other Expenses162.0K184.0K212.0K6.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income28.3M-14.6M13.7M114.3M
 
 
 
 
 
Income Taxes-14.4M-4.3M-6.6M-53.9M
 
 
 
 
 
Minority Interest-3.0K-56.0K-47.0K0.00
 
 
 
 
Net Income13.9M-10.3M7.2M60.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS163.9M164.0M163.7M155.7M
 
 
 
 
 
Shares To Calculate EPS Diluted164.3M164.5M164.0M156.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.08-$0.06$0.04$0.39
 
 
 
 
 
EPS Diluted$0.08-$0.06$0.04$0.39